Pfizer BioNTech Vaccine: Proctects Childern Age of Twelve form Corona!

Oakland (USA) - The BioNTech vaccine also safely protects children between the ages of 12 and 15 from Covid-19 disease. According to researchers, the effectiveness of double vaccination in children 12-15 years old was 100 percent. This has now been shown by published data that was already the basis for the emergency approval of the vaccine in the USA in this age group and that are available to the European Medicines Agency (EMA) for approval testing.

In the study, there were no Covid-19 cases in more than 1000 vaccinated children and adolescents; there were 16 in roughly the same large, unvaccinated control group. After the vaccination there were mostly only slight reactions to the vaccination, such as tiredness or headaches, the scientists write in the "New England Journal of Medicine". The positive results also justify tests on younger children or other groups that are particularly worthy of protection, such as pregnant women, they emphasize.

The effectiveness of BIONTECH-IMPFSTOFF double vaccination is 100 percent according to researchers. The positive results also justify testing younger children or other groups that are particularly worthy of protection, such as pregnant women, emphasize the researchers. The positive results also justify testing younger children or other groups that are particularly worthy of protection, such as pregnant women, emphasize the researchers.

The VACCIN BIONTECH researchers had evaluated data from a total of 2260 children between 12 and 15 years of age. They had received two doses of the vaccine (1131 children) or placebo injections (1129 children) with saline solution 21 days apart. For seven days after each injection, the participants noted any vaccination reactions. Adverse effects were recorded up to six months after the second injection.

According to the researchers, the effectiveness of a double vaccination was 100 percent, since there was no Covid-19 case in the study group compared to the placebo group. Apart from that, laboratory tests also showed that the vaccination produced a stable immune response, it was even better than in the group of adolescents and young adults between 16 and 25 years of age.

As in other age groups, the vaccine reactions when they occurred were mild to moderate. The VACCINO BIONTECH participants complained of pain at the injection site, fatigue, headache, and fever - more frequently after the second dose than after the first. The symptoms usually disappeared within a few days. There were no serious adverse effects such as thrombosis or anaphylactic shock.

NOTE: Hepatitis BIONTECH, BIONTECH ВАКЦИНА, VACUNA BIONTECH THIS IS THE INFORMATION LATEST AND BREAKING NEWS GETTING FROM THE ONLINE SOURCE ON FACEBOOK, GOOGLE, TWITTER, AND SOCIAL MEDIA. VISITORS OR USERS CAN CHECK THE INFORMATION FROM AN OFFICIAL SOURCE. THE HENT GIVING JUST THE INFORMATION ON TEXT OR VIDEO NEWS MEDIA OR ONLINE SOCIAL MEDIA. DIGITAL NEWS. YOU CAN CHECK THE OFFICIAL WEBSITE.

Post a Comment

أحدث أقدم